Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025
October 17, 2025 16:05 ET Â | Source: Jade Biosciences Presentations to highlight…
Vocodia Holdings Corp. and Scale Agile Solutions Announce Letter of Intent for Strategic Asset Acquisition
October 17, 2025 09:00 ET Â | Source: Vocodia Holdings Corp. BOCA RATON,…
AVITA Medical Announces CEO Transition
October 16, 2025 18:15 ET Â | Source: AVITA Medical Board Chairman Cary…
Breker Donates Advanced Test Suite Components to RISC-V International for Use in Future Compliance Activities
October 16, 2025 11:00 ET Â | Source: Breker Verification Systems Donation includes…
TriNetX Becomes the Most Cited Real-World Data Source in Peer-Reviewed Research
With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces…
Annovis Announces Closing of $6 Million Registered Direct Offering of Common Stock
October 15, 2025 17:15 ET Â | Source: Annovis Bio Inc. MALVERN, Pa.,…
EyePoint Announces Proposed Public Offering of Common Stock
October 14, 2025 16:35 ET Â | Source: EyePoint Pharmaceuticals, Inc. WATERTOWN, Mass.,…
Apollomics, Inc. Company Operational Continuity Update
October 13, 2025 21:22 ET Â | Source: Apollomics Inc. FOSTER CITY, Calif.,…
EverQuote to Announce Third Quarter 2025 Financial Results on November 3, 2025
October 13, 2025 16:10 ET Â | Source: EverQuote, Inc. CAMBRIDGE, Mass., Oct.…
HUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO Congress
The fruquintinib and sintilimab combination demonstrated significant PFS improvements in advanced renal…